C43 -Malignant melanoma of skin
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C43 – N =45,696
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 63.4% | 9.5% | 4.6% | 6.2% | 16.4% | 568 |
1983 | 69.6% | 11.7% | 3.7% | 5.2% | 9.8% | 615 |
1984 | 66.4% | 11.5% | 3.9% | 7.7% | 10.5% | 688 |
1985 | 69.8% | 13.5% | 3.8% | 4.1% | 8.7% | 630 |
1986 | 73.3% | 10.1% | 3.4% | 5.7% | 7.5% | 735 |
1987 | 77.6% | 6.6% | 2.5% | 6.4% | 7% | 771 |
1988 | 73.1% | 10% | 1.5% | 7.3% | 8.2% | 854 |
1989 | 76.3% | 8.3% | 2.3% | 5.4% | 7.8% | 822 |
1990 | 74.8% | 7.7% | 1.9% | 5.9% | 9.7% | 834 |
1991 | 76.3% | 6.2% | 2.2% | 6.7% | 8.6% | 900 |
1992 | 76.8% | 7.3% | 1.1% | 6.7% | 8% | 983 |
1993 | 79.4% | 6.7% | 1.5% | 4.1% | 8.3% | 1,108 |
1994 | 73.7% | 7.9% | 5.3% | 5.7% | 7.4% | 1,081 |
1995 | 61% | 16.7% | 9.5% | 5.3% | 7.5% | 1,270 |
1996 | 57.8% | 16.8% | 11.5% | 5.5% | 8.4% | 1,211 |
1997 | 55.5% | 18% | 11.8% | 6.2% | 8.6% | 1,233 |
1998 | 57.4% | 17.7% | 11.1% | 4.4% | 9.4% | 1,315 |
1999 | 57.7% | 17.5% | 12% | 4.2% | 8.7% | 1,358 |
2000 | 57.3% | 18.6% | 11.8% | 6.1% | 6.2% | 1,459 |
2001 | 53.2% | 20.2% | 12.7% | 5.8% | 8.2% | 1,493 |
2002 | 55.8% | 17.8% | 12.9% | 4.8% | 8.7% | 1,594 |
2003 | 57.6% | 19.2% | 10.9% | 4.8% | 7.5% | 1,718 |
2004 | 54.8% | 21.1% | 8.9% | 5.4% | 9.8% | 1,661 |
2005 | 66% | 17.5% | 6.4% | 4.2% | 5.9% | 1,869 |
2006 | 67.5% | 16.3% | 7% | 4.5% | 4.7% | 1,775 |
2007 | 67.2% | 17.7% | 6.3% | 4.6% | 4.1% | 2,049 |
2008 | 67.3% | 16.6% | 7.1% | 5% | 3.9% | 1,907 |
2009 | 65.7% | 17.7% | 8% | 5.1% | 3.5% | 2,113 |
2010 | 66.7% | 17.5% | 8% | 4.5% | 3.4% | 2,082 |
2011 | 66.5% | 18.2% | 8% | 4.3% | 3% | 2,073 |
2012 | 66% | 18.5% | 7.6% | 3.3% | 4.6% | 2,209 |
2013 | 66.7% | 18.2% | 6.7% | 4.2% | 4.1% | 2,309 |
2014 | 68.2% | 17.6% | 6.3% | 3.4% | 4.5% | 2,409 |